Directors and executives at Inotiv Inc. are alleged in a new derivative suit to have harmed the medical research company by concealing beagle puppy deaths at a facility it acquired and illegal primate imports by a supplier.
Recent criminal charges against Inotiv’s principal supplier of nonhuman primates prompted a 57% stock-price drop, investor William Noble Burkhart says in his complaint, filed Wednesday in the US District Court for the Northern District of Indiana.
That followed a 28% stock-price drop and a proposed investor class action sparked by revelations of numerous animal-welfare violations at a Virginia research facility owned by ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
